![](/img/cover-not-exists.png)
PIN7 COST MINIMIZATION ANALYSIS OF ORAL VALGANCICLOVIR VS. INTRAVENOUS AND ORAL GANCICLOVIR IN THE PREVENTION OF CYTOMEGALOVIRUS INFECTION AND DISEASE IN SOLID ORGAN TRANSPLANT RECIPIENTS
M Rubio, F Oppenheimer, S Magaz, X BadiaVolume:
7
Year:
2004
Language:
english
DOI:
10.1016/s1098-3015(10)66024-x
File:
PDF, 66 KB
english, 2004